You are here

Onco-Innovations Limited

Listing Exchange: 
CSE
Status: 
Active
Industry: 
Life Sciences
Symbol: 
ONCO
CSE Index: 
CSE25
Currency: 
CAD

Onco-Innovations Limited is a Canadian biotech company dedicated to developing and commercializing treatments for various types of cancer. The company holds an exclusive license for the PNKP Inhibitor Technology and an exclusive sublicense for the Drug Delivery Technology. Together, these technologies have shown the potential to significantly enhance treatment outcomes, particularly for colorectal cancer.

Onco-Innovations Limited (ONCO)

1.76 Up
0.06 (3.53%)

Onco-Innovations Limited (ONCO)

*Financial charts powered by Quotemedia.com. All right reserved. View the Terms of Use. Data delayed 15 minutes unless indicated.

Quote

Bid Size
6,000 
Bid Price
1.74 
Ask Price
1.76 
Ask Size
1,000 
Volume
144,625 
Last Price
1.76 
Tick
Up 
Net Change
0.06 
Prev Close
1.70 
Open
1.69 
Day High
1.79 
Day Low
1.53 
52 Week High
2.80 
52 Week Low
0.56 
 
 
 
 

*Note: Bid Size and Ask Size fields are displayed as actual quantities

Bid Size
Bid Price
0.00 
Ask Price
0.00 
Ask Size
Volume
Last Price
2.48 
Tick
Up 
Net Change
 
Prev Close
2.48 
Open
0.00 
Day High
0.00 
Day Low
0.00 
52 Week High
 
52 Week Low
 
 
 
 
 

*Note: Bid Size and Ask Size fields are displayed as actual quantities

Quote

Bid Size
6,000 
Bid Price
1.74 
Ask Price
1.76 
Ask Size
1,000 
Volume
144,625 
Last Price
1.76 
Tick
Up 
Net Change
0.06 
Prev Close
1.70 
Open
1.69 
Day High
1.79 
Day Low
1.53 
52 Week High
2.80 
52 Week Low
0.56 
 
 
 
 

*Note: Bid Size and Ask Size fields are displayed as actual quantities

Bid Size
Bid Price
0.00 
Ask Price
0.00 
Ask Size
Volume
Last Price
2.48 
Tick
Up 
Net Change
 
Prev Close
2.48 
Open
0.00 
Day High
0.00 
Day Low
0.00 
52 Week High
 
52 Week Low
 
 
 
 
 

*Note: Bid Size and Ask Size fields are displayed as actual quantities

Depth Display By Order

Bid Broker Bid Size Bid Price Ask Price Ask Size Ask Broker
Canaccord Capital Corporation 6,000 1.74 1.76 1,000 Instinet Canada Limited
W.D. Latimer Co. Limited 500 1.68 1.79 400 Anonymous
W.D. Latimer Co. Limited 500 1.65 1.80 500 Anonymous
W.D. Latimer Co. Limited 500 1.60 1.85 500 Anonymous
W.D. Latimer Co. Limited 1,000 1.55 1.90 500 Anonymous
Questrade Inc. 1,000 1.53 1.94 2,500 Virtu Canada Corp.
Anonymous 500 1.52 2.00 500 Anonymous
W.D. Latimer Co. Limited 1,000 1.50 2.05 100 National Bank Financial Inc.
Canaccord Capital Corporation 5,000 1.50 2.10 2,000 National Bank Financial Inc.
Canaccord Capital Corporation 5,000 1.45 2.20 1,000 TD Securities Inc.
Bid Broker Bid Size Bid Price Ask Price Ask Size Ask Broker
0 0.00 0.00 0
0 0.00 0.00 0
0 0.00 0.00 0
0 0.00 0.00 0
0 0.00 0.00 0
0 0.00 0.00 0
0 0.00 0.00 0
0 0.00 0.00 0
0 0.00 0.00 0
0 0.00 0.00 0

Depth Display By Price

Bid Count Bid Size Bid Price Ask Price Ask Size Ask Count
1 6,000 1.74 1.76 1,000 1
1 500 1.68 1.79 400 1
1 500 1.65 1.80 500 1
1 500 1.60 1.85 500 1
1 1,000 1.55 1.90 500 1
Bid Count Bid Size Bid Price Ask Price Ask Size Ask Count
0 0 0.00 0.00 0 0
0 0 0.00 0.00 0 0
0 0 0.00 0.00 0 0
0 0 0.00 0.00 0 0
0 0 0.00 0.00 0 0

Recent Trades

Date/Time Price Change Volume Buyer Seller Venue
Mar 28, 19:59 1.76 0.06 1,000 Anonymous Instinet Canada Limited CSE
Mar 28, 19:59 1.76 0.06 500 Canaccord Capital Corporation Instinet Canada Limited CSE
Mar 28, 19:59 1.76 0.06 1,000 Canaccord Capital Corporation Instinet Canada Limited CSE
Mar 28, 19:59 1.76 0.06 1,000 Canaccord Capital Corporation Instinet Canada Limited CSE
Mar 28, 19:59 1.76 0.06 1,000 Canaccord Capital Corporation Instinet Canada Limited CSE

Company Info

Address
1309-7th Street SW
Vancouver, BC V6C 2B5
Canada
Phone
(236) 521-0626
Email
nl@amalficorp.ca
Website
https://www.oncoinnovations.com
Listing date
Tuesday, November 26, 2024
Transfer Agent
Endeavor Trust Corporation

SEDAR Information

Filing Type Any News Releases Material Change Report Management's Discussion & Analysis Financial Statements
Timeframe 1 week1 month3 month6 month1 yearAll Time

Company Info

Address
1309-7th Street SW
Vancouver, BC V6C 2B5
Canada
Phone
(236) 521-0626
Email
nl@amalficorp.ca
Website
https://www.oncoinnovations.com
Listing date
Tuesday, November 26, 2024
Transfer Agent
Endeavor Trust Corporation

Capitalization

Issued & Outstanding: 
47153310
Reserved for Issuance: 
8006583

Company Officers

Thomas O'Shaughnessy, CEO
Nico Mah, CFO and Corporate Secretary

Bulletins

26/11/2024

2024-1133 - New Listing - Onco-Innovations Limited (ONCO)

Le 26 novembre/November 2024

The common shares of Onco-Innovations Limited have been approved for listing on the CSE.

Listing and disclosure documents will be available at www.thecse.com on the trading date.